Overview
X-linked fetal akinesia syndrome, also known as X-linked lethal arthrogryposis with intrauterine growth retardation (IUGR), is an extremely rare and severe genetic disorder characterized by markedly reduced or absent fetal movement during pregnancy. This condition predominantly affects males and is caused by mutations in genes on the X chromosome. The syndrome falls within the broader spectrum of fetal akinesia deformation sequence (FADS), in which lack of fetal movement leads to a cascade of secondary developmental abnormalities. The hallmark features include severe arthrogryposis multiplex congenita (multiple joint contractures), intrauterine growth restriction, fetal hydrops (abnormal fluid accumulation), pulmonary hypoplasia (underdeveloped lungs), and characteristic facial anomalies such as a small jaw (micrognathia) and low-set ears. Polyhydramnios (excess amniotic fluid) is frequently observed during pregnancy due to impaired fetal swallowing. The musculoskeletal, respiratory, and central nervous systems are primarily affected. Thin, gracile bones and decreased muscle mass are commonly noted. Pterygia (skin webbing across joints) and cystic hygroma may also be present. The prognosis is extremely poor, with most affected males dying in utero or shortly after birth, primarily due to respiratory failure from pulmonary hypoplasia. Female carriers are typically unaffected or may show very mild features. There is currently no curative treatment available. Management is supportive and palliative. Genetic counseling is essential for affected families, and prenatal diagnosis may be possible through ultrasound detection of reduced fetal movements and molecular genetic testing when the causative mutation has been identified in the family.
Also known as:
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for X-linked fetal akinesia syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for X-linked fetal akinesia syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for X-linked fetal akinesia syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to X-linked fetal akinesia syndrome.
Community
No community posts yet. Be the first to share your experience with X-linked fetal akinesia syndrome.
Start the conversation →Latest news about X-linked fetal akinesia syndrome
No recent news articles for X-linked fetal akinesia syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about X-linked fetal akinesia syndrome
What is X-linked fetal akinesia syndrome?
X-linked fetal akinesia syndrome, also known as X-linked lethal arthrogryposis with intrauterine growth retardation (IUGR), is an extremely rare and severe genetic disorder characterized by markedly reduced or absent fetal movement during pregnancy. This condition predominantly affects males and is caused by mutations in genes on the X chromosome. The syndrome falls within the broader spectrum of fetal akinesia deformation sequence (FADS), in which lack of fetal movement leads to a cascade of secondary developmental abnormalities. The hallmark features include severe arthrogryposis multiplex
How is X-linked fetal akinesia syndrome inherited?
X-linked fetal akinesia syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does X-linked fetal akinesia syndrome typically begin?
Typical onset of X-linked fetal akinesia syndrome is neonatal. Age of onset can vary across affected individuals.